128 related articles for article (PubMed ID: 36696653)
21. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
Bosco JL; Halpenny B; Berry DL
Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
[TBL] [Abstract][Full Text] [Related]
22. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
[TBL] [Abstract][Full Text] [Related]
23. Emotional Distress Increases the Likelihood of Undergoing Surgery among Men with Localized Prostate Cancer.
Orom H; Underwood W; Biddle C
J Urol; 2017 Feb; 197(2):350-355. PubMed ID: 27506694
[TBL] [Abstract][Full Text] [Related]
24. Racial Disparities in Active Surveillance for Prostate Cancer.
Krishna S; Fan Y; Jarosek S; Adejoro O; Chamie K; Konety B
J Urol; 2017 Feb; 197(2):342-349. PubMed ID: 27596691
[TBL] [Abstract][Full Text] [Related]
25. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
26. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
27. Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.
Bayliss DR; Duff J; Stricker P; Walker K
Urol Nurs; 2017; 37(1):15-22. PubMed ID: 29240360
[TBL] [Abstract][Full Text] [Related]
28. Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer.
Smith A'; Rincones O; Mancuso P; Sidhom M; Wong K; Berry M; Forstner D; Ngo D; Bokey L; Girgis A
Urol Oncol; 2022 Jan; 40(1):8.e1-8.e9. PubMed ID: 34116935
[TBL] [Abstract][Full Text] [Related]
29. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
30. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.
Ramsey SD; Zeliadt SB; Fedorenko CR; Blough DK; Moinpour CM; Hall IJ; Smith JL; Ekwueme DU; Fairweather ME; Thompson IM; Keane TE; Penson DF
World J Urol; 2011 Feb; 29(1):3-9. PubMed ID: 20959991
[TBL] [Abstract][Full Text] [Related]
31. Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina.
Wagner SE; Drake BF; Elder K; Hébert JR
Cancer Causes Control; 2011 Nov; 22(11):1597-606. PubMed ID: 21877121
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
33. Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.
Filson CP; Hong F; Xiong N; Pozzar R; Halpenny B; Berry DL
Cancer; 2021 Jan; 127(2):203-208. PubMed ID: 33119142
[TBL] [Abstract][Full Text] [Related]
34. Patient reported factors influencing the decision-making process of men with localised prostate cancer when considering Active Surveillance-A systematic review and thematic synthesis.
Cunningham M; Murphy M; Sweeney P; Richards HL
Psychooncology; 2022 Mar; 31(3):388-404. PubMed ID: 34605104
[TBL] [Abstract][Full Text] [Related]
35. Men's perspectives on selecting their prostate cancer treatment.
Xu J; Dailey RK; Eggly S; Neale AV; Schwartz KL
J Natl Med Assoc; 2011 Jun; 103(6):468-78. PubMed ID: 21830629
[TBL] [Abstract][Full Text] [Related]
36. Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?
Radhakrishnan A; Grande D; Mitra N; Pollack CE
Urology; 2018 May; 115():133-138. PubMed ID: 29477313
[TBL] [Abstract][Full Text] [Related]
37. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.
Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Stewart ST; Bhatnagar V; Sweeney CJ; Stahl JE; McMahon PM
JAMA; 2010 Dec; 304(21):2373-80. PubMed ID: 21119084
[TBL] [Abstract][Full Text] [Related]
38. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
[TBL] [Abstract][Full Text] [Related]
40. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.
Myers RE; Leader AE; Censits JH; Trabulsi EJ; Keith SW; Petrich AM; Quinn AM; Den RB; Hurwitz MD; Lallas CD; Hegarty SE; Dicker AP; Zeigler-Johnson CM; Giri VN; Ayaz H; Gomella LG
J Cancer Educ; 2018 Feb; 33(1):180-185. PubMed ID: 27418065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
